COMMON STOCK PURCHASE WARRANT SEELOS THERAPEUTICS, INC.Seelos Therapeutics, Inc. • May 19th, 2023 • Pharmaceutical preparations
Company FiledMay 19th, 2023 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 19, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 20, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Seelos Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AMENDMENT NO. 1 to SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2023 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 19th, 2023 Company Industry JurisdictionThis Amendment No. 1 to Securities Purchase Agreement (this “Amendment”) is dated as of May 19, 2023, among Seelos Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).